Kristin Narayan

512 total citations
13 papers, 216 citations indexed

About

Kristin Narayan is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Kristin Narayan has authored 13 papers receiving a total of 216 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Kristin Narayan's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers) and Influenza Virus Research Studies (3 papers). Kristin Narayan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (5 papers) and Influenza Virus Research Studies (3 papers). Kristin Narayan collaborates with scholars based in United States, Ukraine and France. Kristin Narayan's co-authors include Zachary Shriver, Gregory J. Babcock, Andrew M. Wollacott, Karthik Viswanathan, Boopathy Ramakrishnan, José Trevejo, Patrick F. Smith, David Oldach, Susan Sloan and Catherine A. Hay and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Kristin Narayan

12 papers receiving 212 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristin Narayan United States 7 80 78 69 59 59 13 216
Maddy L. Newby United Kingdom 13 225 2.8× 71 0.9× 52 0.8× 107 1.8× 88 1.5× 19 369
Matthew D. Slein United States 6 211 2.6× 54 0.7× 74 1.1× 43 0.7× 96 1.6× 9 302
Ian Setliff United States 8 63 0.8× 35 0.4× 64 0.9× 79 1.3× 86 1.5× 12 223
Harini Natarajan United States 7 125 1.6× 45 0.6× 62 0.9× 50 0.8× 102 1.7× 10 243
Jan Spitaels Belgium 5 53 0.7× 79 1.0× 35 0.5× 42 0.7× 67 1.1× 5 159
Thomas N. Denny United States 8 30 0.4× 43 0.6× 64 0.9× 76 1.3× 132 2.2× 11 226
Marloes Grobben Netherlands 8 66 0.8× 27 0.3× 38 0.6× 21 0.4× 47 0.8× 18 135
Fernanda Ana‐Sosa‐Batiz Australia 10 83 1.0× 198 2.5× 101 1.5× 59 1.0× 199 3.4× 17 365
Ashlin R. Michell United States 6 62 0.8× 28 0.4× 36 0.5× 36 0.6× 71 1.2× 7 166
Jennifer Galli United States 7 66 0.8× 117 1.5× 25 0.4× 30 0.5× 21 0.4× 14 183

Countries citing papers authored by Kristin Narayan

Since Specialization
Citations

This map shows the geographic impact of Kristin Narayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristin Narayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristin Narayan more than expected).

Fields of papers citing papers by Kristin Narayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristin Narayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristin Narayan. The network helps show where Kristin Narayan may publish in the future.

Co-authorship network of co-authors of Kristin Narayan

This figure shows the co-authorship network connecting the top 25 collaborators of Kristin Narayan. A scholar is included among the top collaborators of Kristin Narayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristin Narayan. Kristin Narayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Wolfe, Cameron R., Jonathan Cohen, Anna Holmes, et al.. (2025). Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY). Clinical Infectious Diseases. 81(3). 439–450. 1 indexed citations
2.
3.
Ison, Michael G., Debra F. Weinstein, Anna Holmes, et al.. (2023). Prevention of COVID-19 Following a Single Intramuscular Administration of Adintrevimab: Results From a Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial (EVADE). Open Forum Infectious Diseases. 10(7). ofad314–ofad314. 7 indexed citations
4.
5.
Schmidt, Peter, Kristin Narayan, Yong Li, et al.. (2023). Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers. Science Translational Medicine. 15(688). eadg2783–eadg2783. 12 indexed citations
6.
Zumbrun, Elizabeth E., Chengzi I. Kaku, Samantha E. Zak, et al.. (2022). Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19. Antimicrobial Agents and Chemotherapy. 67(1). e0135322–e0135322. 2 indexed citations
7.
8.
9.
Sloan, Susan, Kristy J. Szretter, Bharathi Sundaresh, et al.. (2020). Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study. Antiviral Research. 184. 104763–104763. 20 indexed citations
10.
Hershberger, Ellie, Susan Sloan, Kristin Narayan, et al.. (2019). Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study. EBioMedicine. 40. 574–582. 63 indexed citations
11.
Ramakrishnan, Boopathy, Kristin Narayan, Andrew M. Wollacott, et al.. (2018). Extending human IgG half-life using structure-guided design. mAbs. 10(7). 1–13. 76 indexed citations
12.
Gach, Johannes S., Heribert Quendler, Tommy Tong, et al.. (2013). A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1. PLoS ONE. 8(8). e72054–e72054. 16 indexed citations
13.
Narayan, Kristin, Daniel P. Leaman, Pham Phung, et al.. (2013). Prime-Boost Immunization of Rabbits with HIV-1 gp120 Elicits Potent Neutralization Activity against a Primary Viral Isolate. PLoS ONE. 8(1). e52732–e52732. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maddy L. Newby Breakdown of academic impact, for papers by Matthew D. Slein Breakdown of academic impact, for papers by Ian Setliff Breakdown of academic impact, for papers by Harini Natarajan Breakdown of academic impact, for papers by Jan Spitaels Breakdown of academic impact, for papers by Thomas N. Denny Breakdown of academic impact, for papers by Marloes Grobben Breakdown of academic impact, for papers by Fernanda Ana‐Sosa‐Batiz Breakdown of academic impact, for papers by Ashlin R. Michell Breakdown of academic impact, for papers by Jennifer Galli
Rankless by CCL
2026